Cargando…

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening

BACKGROUND: The increasingly complex programs of contemporary cancer therapy emphasize the need for biological indicators of both therapeutic response and adverse effects. One example is combined-modality treatment aimed at improving long-term outcome in patients with locally advanced rectal cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalanxhi, Erta, Hektoen, Helga Helseth, Meltzer, Sebastian, Dueland, Svein, Flatmark, Kjersti, Ree, Anne Hansen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962367/ https://www.ncbi.nlm.nih.gov/pubmed/27461255 http://dx.doi.org/10.1186/s12885-016-2601-x

Ejemplares similares

Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2016)

Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks
por: Ree, Anne Hansen, et al.
Publicado: (2014)

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
por: Hektoen, Helga Helseth, et al.
Publicado: (2015)

Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Corrigendum to “Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer” [Transl Oncol 12 (8) (2019) 1038–1044]
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy
por: Ree, Anne Hansen, et al.
Publicado: (2014)

Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
por: Kalanxhi, Erta, et al.
Publicado: (2018)

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
por: Abrahamsson, Hanna, et al.
Publicado: (2019)

Immune-Modulating Effects of Conventional Therapies in Colorectal Cancer
por: Kalanxhi, Erta, et al.
Publicado: (2020)

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
por: Bains, Simer J., et al.
Publicado: (2019)

Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
por: Kalanxhi, Erta, et al.
Publicado: (2017)

Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer()()
por: Bousquet, Paula A., et al.
Publicado: (2018)

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
por: Saelen, Marie Grøn, et al.
Publicado: (2012)

The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2021)

Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
por: Bratland, Åse, et al.
Publicado: (2011)

Tumor Phosphatidylinositol-3-Kinase Signaling and Development of Metastatic Disease in Locally Advanced Rectal Cancer
por: Ree, Anne Hansen, et al.
Publicado: (2012)

Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
por: Saelen, Marie Grøn, et al.
Publicado: (2011)

ASO Author Reflections: Navigation-Assisted Surgery for Locally Advanced and Recurrent Rectal Cancer: The NAVI-LARRC Trial
por: Solbakken, Arne M., et al.
Publicado: (2023)

Confidence interval methods for antimicrobial resistance surveillance data
por: Kalanxhi, Erta, et al.
Publicado: (2021)

Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2022)

Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2021)

Energy Metabolism Is Altered in Radioresistant Rectal Cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning (1)H magnetic resonance spectroscopy
por: Seierstad, Therese, et al.
Publicado: (2008)

An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer
por: Bjørnetrø, Tonje, et al.
Publicado: (2019)

Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
por: Abrahamsson, Hanna, et al.
Publicado: (2021)

The metastasis-associated protein S100A4 exists in several charged variants suggesting the presence of posttranslational modifications
por: Haugen, Mads H, et al.
Publicado: (2008)

A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases
por: Nygaard, Vigdis, et al.
Publicado: (2023)

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
por: Flatmark, Kjersti, et al.
Publicado: (2006)

Fibromatosis in vertical rectus abdominis myocutaneous flap imitating tumor recurrence after surgery for locally advanced rectal cancer: case report
por: Goscinski, Mariusz Adam, et al.
Publicado: (2016)

Modal array signal processing
por: Teutsch, Heinz
Publicado: (2007)

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
por: Flatmark, Kjersti, et al.
Publicado: (2020)

ASO Author Reflections: The Peritoneum is an Active Immunological Compartment
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2021)

The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
por: Line, Pål-Dag, et al.
Publicado: (2018)

Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
por: Gislefoss, Randi Elin, et al.
Publicado: (2018)

From antibiotics to ibrutinib: An array of treatment modalities
por: Thieblemont, Catherine
Publicado: (2018)

Variation in the Height of Rectal Cancers According to the Diagnostic Modalities
por: Yeom, Seung-Seop, et al.
Publicado: (2019)

Current diagnostic tools and treatment modalities for rectal prolapse
por: Oruc, Mustafa, et al.
Publicado: (2023)

Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
por: Bratseth, Vibeke, et al.
Publicado: (2022)

Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
por: Dagenborg, Vegar Johansen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n9vilkh4a1d1edvhtc96hvo9t4